|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4704 | (2006.01) |
| A61K 31/4704 | (2013.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61K 31/573 | (2006.01) | ||
| A61K 31/573 | (2013.01) |
| (11) | Number of the document | 3797772 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19020504.7 |
| Date of filing the European patent application | 2019-09-03 | |
| (97) | Date of publication of the European application | 2021-03-31 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-18 |
| (46) | Date of publication of the claims translation |
| (72) |
| (73) |
SQUARE POWER LTD ,
2nd Floor, 9 Chapel Place, London EC2A 3DQ,
GB
|
| (54) | REBAMIPIDE FOR USE IN PREVENTION AND TREATMENT OF CROHN'S DISEASE |
| REBAMIPIDE FOR USE IN PREVENTION AND TREATMENT OF CROHN'S DISEASE |